Efficacy and Safety of Fludarabine and Cyclophosphamide Combined Therapy in Patients with Refractory/Recurrent B-Cell Chronic Lymphocytic Leukaemia (B-CLL)—Polish Multicentre Study

Reference

• Cheson, B.D. (1998) "New prospects in the treatment of indolent lymphomas with purine analogues", Cancer Journal of Scientific American 4 (suppl. 2), S27–36.
   PubMed Web of Science ®Google Scholar
• Bellosillo, B., Villamor, N., Colomer D., et al. (1999) "In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia", Blood, 94, 2836–2843.
   PubMed Web of Science ®Google Scholar
• Cheson, B.D., Bennett, J.M., Greyer, M., et al. (1996) "National Cancer Institute-Sponsored Working Group guidelines for diag-nosis and treatment", Blood, 87, 4990–4997
   Google Scholar
• Keating, M.J. (1999) "Chronic lymphocytic leukemia", Seminars in Oncology, 26(5 suppl 14), 107–114.
   PubMed Web of Science ®Google Scholar
• CLL Trialists' Collaborative Group (1999) "Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials", Journal of National Cancer Institute, 91, 861 — 868.
   Google Scholar
• O'Brien, S., Kantarjian, H.M., Cortes, J., et al. (2001) "Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", Journal of Clinical Oncology, 19, 1414 — 1420.
   Google Scholar
• Robak, T., Blasinska-Morawiec, M., Krykowski, E., et al. (1996) "Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadeno-sine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma, 22, 509 — 514.
   Google Scholar
• Leporrier, M., Chevret, S., Cazin, B., et al. (2001) "For the French Cooperative Group on Chronic Lymphocytic Leukemia. Rando-mized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", Blood, 98, 2319–2325.
   PubMed Web of Science ®Google Scholar
• Hallek, M., Schmitt, B., Wilhelm, M., et al. (2001) "Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group". British Journal of Haematology 114, 342 — 348.
   PubMed Web of Science ®Google Scholar
• Bosanquet, A.G., Johnson, S.A. and Richards, S.M. (1999) "Prognosis for fludarabine therapy of chronic lymphocytic leukae-mia based on ex vivo drug response by DiSC assay", British Journal of Haematology, 106, 71 — 77
   Google Scholar
• Frewin, R., Turner, D., Tighe, M., et al. (1999) "Combination therapy with fludarabine and cyclophosphamide as salvage treat-ment in lymphoproliferative disorders". British Journal of Haema-tology, 104, 612–613.
   PubMed Web of Science ®Google Scholar
• Keating, M.J., O'Brien, S., Lerner, S., et al. (1998) "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy". Blood, 92, 1165 — 1171.
   Google Scholar
• Bosch, F., Ferrer, A., Lopez-Guillermo, A., et al. (2002) "Fludar-abine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia", British Journal of Haematology, 119, 976 —984.
   Google Scholar
• Montillo, M., Tedeschi, A., O'Brien, S., et al. (2003) "Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia". Cancer, 97, 114 — 120.
   Google Scholar
• Robak, T., Blonski, J.Z., Kasznicki, M., et al. (2002) "Re-treatment with cladribine — based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment", European Journal of Haematology, 69, 27 — 36.
   PubMed Web of Science ®Google Scholar
• Robak, T., }Rash, J.Z., Kasznicki, M., et al. (2002) "Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymohocytic leukemia". The Hematology Journal, 3\(supp1.1), 247, abs.824.
   Google Scholar
• Perkins, J.G., Flynn, J.M., Howard, R.S. and Byrd, J.C. (2002) "Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: Implications for clinical trials in this population". Cancer, 94, 2033–2039.
   Google Scholar
• Kowal, M., Dmoszynska, A., Koktysz, M. and Malik°, J. (1999) "Infectious complications during 2-chlorodeoxyadenosine therapy". Ann. Univ. M. Curie-Sklodowska, UV, 75–83.
   Google Scholar
• Hamblin, T. (2001) "Autoimmune disease and its management in chronic lymphocytic leukemia. In Chronic lymphoid leukemias, edited by B.D. Cheson. Pp. 435–458. New York: Marcel Dekker, Inc.
   Google Scholar
• Johnson, S., Smith, A.G., Loifier, H., et al. For French Cooperative Group on CLL . (1996) "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicine, and pre-dnisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia". Lancet, 347, 1432— 1438.
   Google Scholar
• Robak, T., }Rash, J.Z., Kasznicki, M., et al. (2000) "Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial". Blood, 96, 2723–2729
   PubMed Web of Science ®Google Scholar
• Keating, M.J., Kantarjian, H., Talpaz, M., et al. (1989) "Fludar-abine: a new agent with major activity against chronic lymphocytic leukemia", Blood, 74, 19–25.
   Google Scholar
• Boogaerts, M. (2000) New options for first- and second-line CLL treatment. Satellite symposium Schering AG:Haematological ma-lignancies-latest advances and future directions. EHA, Birmingham, June 2000.
   Google Scholar
• Lauria, F., Rondelli, D., Raspadori, D., et al. (1994) "Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia". European Journal of Haematology, 52, 16–20.
   PubMed Web of Science ®Google Scholar
• Dmoszynska, A., Legieé, W. and Wach, M. (1999) "Attempted reconstruction of the immune system using low dose of interleukin 2 in chronic lymphocytic leukemia patients treated with 2-chloro-deoxyadenosine: results of a pilot study". Leukemia and Lymphoma, 34, 335 — 340.
   PubMed Web of Science ®Google Scholar